Women's Health Investment Gap Signals $100 Billion Opportunity
Event summary
- Private healthcare investment in women's health represents only 6% of total investment, despite women comprising nearly half the global population.
- 90% of this limited investment is concentrated in women's cancers, reproductive health, and maternal health.
- Conditions like cardiovascular disease, osteoporosis, menopause, and Alzheimer's, which disproportionately affect women, are significantly underfunded.
- The underinvestment represents a potential $100 billion market opportunity by 2030 if women received standard care.
- The report highlights areas like women's cancer therapeutics and virtual healthcare as showing investment momentum.
The big picture
The stark investment disparity highlights a systemic bias in healthcare research and development, historically prioritizing male physiology. This represents a significant market inefficiency and a potential misalignment with evolving societal priorities and demographic shifts, as women increasingly drive healthcare consumption and workforce participation. The $100 billion opportunity underscores the potential for substantial returns for investors willing to address this underserved market.
What we're watching
- Regulatory Headwinds
- The report's call for modernized regulatory frameworks to lower entry barriers will require sustained advocacy and may face resistance from established players.
- Execution Risk
- The success of replicating the IVF market's growth will depend on demonstrating clear economic returns and expanding the evidence base for underfunded conditions, a process that could be lengthy and costly.
- Governance Dynamics
- The call for blended finance and collaborative efforts suggests a shift towards more complex investment structures, which could introduce new governance challenges and require specialized expertise.
Related topics